Elizabeth Cunningham
Impact in
- Biotechnology top 5%
- Cancer Research and Treatments
- Oncology top 10%
- Colorectal Cancer Treatments and Studies
Papers in
-
- Schizophrenia research and treatment 4
- Epilepsy research and treatment 3
- Electroconvulsive Therapy Studies 2
-
- Melanoma and MAPK Pathways 3
- Co-authors
- Lance S. Evans (4 shared papers)Tapas K. Das Gupta (2 shared papers)Ananda M. Chakrabarty (2 shared papers)Dibyen Majumdar (2 shared papers)Vasu Punj (2 shared papers)Tohru Yamada (2 shared papers)Keith F. Lewin (4 shared papers)Adil Daud (3 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)Epilepsy & Behavior (2 papers)New Phytologist (2 papers)Oncotarget (1 paper)American Journal of Industrial Medicine (1 paper)
- Partner nations
- United StatesAustraliaAustria
In The Last Decade
Elizabeth Cunningham
28 papers receiving 921 citations
Hit Papers
Peers
Comparison fields: 5 of 125
- Biotechnology 200
- Oncology 432
- Pathology and Forensic Medicine 186
- Cancer Research 129
- Molecular Biology 336
Countries citing papers authored by Elizabeth Cunningham
This map shows the geographic impact of Elizabeth Cunningham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Cunningham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Cunningham more than expected).
Fields of papers citing papers by Elizabeth Cunningham
This network shows the impact of papers produced by Elizabeth Cunningham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Cunningham. The network helps show where Elizabeth Cunningham may publish in the future.
Co-authors
The 25 scholars most cited alongside Elizabeth Cunningham, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Combined BRAF and MEK Inhibition With Dabrafenib and Trametinib in BRAF V600–Mutant Colorectal Cancer Hit paper breakdown → | 2015 | 382 |
| 2 | 2002 | 152 | |
| 3 | 2004 | 138 | |
| 4 | 1983 | 43 | |
| 5 | 1982 | 34 | |
| 6 | 2014 | 26 | |
| 7 | 2013 | 23 | |
| 8 | 2014 | 21 | |
| 9 | 1983 | 18 | |
| 10 | 2017 | 16 | |
| 11 | 2019 | 16 | |
| 12 | 2017 | 12 | |
| 13 | 2015 | 11 | |
| 14 | 1982 | 10 | |
| 15 | 2017 | 10 | |
| 16 | 2021 | 9 | |
| 17 | 1998 | 6 | |
| 18 | 2001 | 5 | |
| 19 | 2021 | 4 | |
| 20 | 1996 | 4 |
About Elizabeth Cunningham
Elizabeth Cunningham is a scholar working on Psychiatry and Mental health, Molecular Biology, Plant Science, Neurology and Oncology, having authored 32 papers that have together received 955 indexed citations. Recurring topics across this work include Plant responses to elevated CO2 (4 papers), Schizophrenia research and treatment (4 papers), Melanoma and MAPK Pathways (3 papers), Epilepsy research and treatment (3 papers), Nanoplatforms for cancer theranostics (2 papers), Long-Term Effects of COVID-19 (2 papers), Cancer Research and Treatments (2 papers) and Electroconvulsive Therapy Studies (2 papers). The work is most often cited by research in Biotechnology (200 citations), Oncology (432 citations), Pathology and Forensic Medicine (186 citations), Cancer Research (129 citations) and Molecular Biology (336 citations). Elizabeth Cunningham has collaborated with scholars based in United States, Australia and Austria. Frequent co-authors include Lance S. Evans, Tapas K. Das Gupta, Ananda M. Chakrabarty, Dibyen Majumdar, Vasu Punj, Tohru Yamada, Keith F. Lewin, Adil Daud, Omid Hamid and Peng Sun. Their work appears in journals such as Journal of Clinical Oncology, Epilepsy & Behavior, New Phytologist, Oncotarget and American Journal of Industrial Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.